Analyst ratings, especially from reputable firms like Jefferies, can significantly influence investor sentiment and stock prices. A Buy rating combined with a price target that suggests substantial upside potential is likely to generate positive investor interest in the short term. Given that this is a new coverage initiation, it may attract additional attention to Tempest Therapeutics, potentially driving up the stock price as investors align with the analyst's positive outlook.